Oxidized low-density lipoproteins and their contribution to atherosclerosis
Reviews on Clinical Pharmacology and Drug Therapy · 15.12.2024 · 22 (4) · 351-360
DOI: 10.17816/rcf633567 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reviews on Clinical Pharmacology and Drug Therapy, online erschienen am 15.12.2024. Verfasst von Abdullatif Taha Babakr. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Lipoprotein oxidation is a critical early stage in the development of atherosclerosis, a disease characterized by the formation of plaque in arterial walls. It has been well-established that the oxidation of low-density lipoprotein (LDL) is a key factor in the progression of atherosclerosis. Oxidized LDL (Ox-LDL) possesses a range of atherogenic properties, contributing to endothelial dysfunction, foam cell formation, and inflammation within the arterial wall. The interaction between Ox-LDL and specific receptors on endothelial cells plays a crucial role in these processes. In this article, we will discuss the oxidation of LDL and the pro-atherogenic role of Ox-LDL, we will delve into the different types of LDL receptors involved in the uptake and metabolism of LDL, with a focus on their role in atherosclerosis. We will explore the mechanisms by which native LDL (nLDL) and Ox-LDL interact with these receptors, leading to the development and progression of atherosclerotic plaques. Then we will go through more in-depth discussion to explore the intricate role of scavenger receptors in the uptake of oxidized low-density lipoproteins (Ox-LDL) and their significant contribution to the pathogenesis of atherosclerosis. Understanding the intricacies of these receptor-ligand interactions is essential for developing targeted therapeutic strategies to combat atherosclerosis and its associated complications.
Zitieren
APA
Babakr, A. T. (2024). Oxidized low-density lipoproteins and their contribution to atherosclerosis. Reviews on Clinical Pharmacology and Drug Therapy, 22(4), 351-360. https://doi.org/10.17816/rcf633567
Vancouver
Babakr AT. Oxidized low-density lipoproteins and their contribution to atherosclerosis. Reviews on Clinical Pharmacology and Drug Therapy. 2024;22(4):351-360. doi:10.17816/rcf633567
BibTeX
@article{Babakr2024,
author = {Babakr, Abdullatif Taha},
title = {Oxidized low-density lipoproteins and their contribution to atherosclerosis},
journal = {Reviews on Clinical Pharmacology and Drug Therapy},
year = {2024},
volume = {22},
number = {4},
pages = {351--360},
doi = {10.17816/rcf633567}
}
EUVIMED